Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (547)	3/8/2000 3:40:00 PM
From: scott_jiminez	Read Replies (1) \| Respond to of 675

Mike - perhaps some folks on SI appreciate your glib attitude about researching an equity. Can't say that I do. For someone who didn't know the difference between a central and peripheral myelin forming cell, it's a bit much (UNDERSTATEMENT) being told my selection process involves 'fairy dust' and pump and dump. Perhaps you simply don't understand CNSI's science. That's fine. I DO! That is exactly why I placed post 546. You can invoke all this stuff about CNSI's listing, phantom newsletters, etc..without ever discussing the science. So be it. But please don't address those type of posts to me. If you understand the mechanism of action of GGF2, and the importance of being associated with Cedric Raine (as I said here siliconinvestor.com, you might be able to grasp the underlying logic of my enthusiasm. (and if that's 'pumping', it's pales - by orders of magnitude - compared to Richard Harmon's statements (for years!) puffing up Gliatech)